Feedback PLC Director/PDMR Shareholding: Correction (6554K)

TIDMFDBK

RNS Number : 6554K

Feedback PLC

22 December 2022

Feedback plc

Director Dealings

Further to announcement 5307K, made on 22 December 2022 at 07:00, outlining Director Dealings, the Company notes that, due to a clerical error, the shares were described as being "subscribed for" rather than "purchased" and the nominal value was given as "0.50 pence", not "GBP0.50". These were "Ordinary Shares" and not "New Ordinary Shares". There have been no other amends than clarification of purchasing of existing ordinary shares and amended nominal value.

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the frontline clinical technology company, announces the following Directors' dealings:

Rory Shaw, Non Executive Chairman, has purchased 22,270 Ordinary Shares at a price of 89.8 pence per Ordinary Share.

Philipp Prince, Non Executive Director, has purchased 4,531 Ordinary Shares at a price of 89.9 pence per Ordinary Share.

Annemijn Eschauzier, Non Executive Director, has purchased 5,440 Ordinary Shares at a price of 91.9 pence per Ordinary Share.

Details of the Ordinary Shares held by these Directors are detailed in the table below:

 
 Director/      Position           Existing             Ordinary              Total beneficial     Total interest 
  PDMR                              interest in          Shares purchased      interest in          in Company's 
                                    Ordinary Shares                            Ordinary Shares      issued share 
                                                                                                    capital 
                Non-Executive 
 Rory Shaw       Chairman          56,303               22,270                78,573               0.59% 
               ---------------  -------------------  --------------------  -------------------  ----------------- 
 Philipp        Non-Executive 
  Prince         Director          20,232               4,531                 24,763               0.19% 
               ---------------  -------------------  --------------------  -------------------  ----------------- 
 Annemijn       Non-Executive 
  Eschauzier     Director          -                    5,440                 5,440                0.04% 
               ---------------  -------------------  --------------------  -------------------  ----------------- 
 

The notification set out below, provides further details of such dealings:

 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Names                                    Rory Shaw 
                                                 Philipp Prince 
                                                 Annemijn Eschauzier 
      ---------------------------------------  ------------------------------------------------- 
       Reason for the notification 
  2 
      ------------------------------------------------------------------------------------------ 
 a)    Position/status                          Non-Executive Chairman 
                                                 Non-Executive Director 
                                                 Non-Executive Director 
      ---------------------------------------  ------------------------------------------------- 
 b)    Initial notification                     Initial notification 
        /Amendment 
      ---------------------------------------  ------------------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------------ 
 a)    Name                                     Feedback plc 
      ---------------------------------------  ------------------------------------------------- 
 b)    LEI                                      213800UGOF2GT2U2RV90 
      ---------------------------------------  ------------------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4     for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ------------------------------------------------------------------------------------------ 
 a)    Description of the                       Ordinary Shares of GBP0.50 each in Feedback 
        financial instrument,                    plc 
        type of instrument 
 
       Identification code                      GB00BJN59X09 
 
 b)    Nature of the transaction                Purchase of Ordinary Shares 
      ---------------------------------------  ------------------------------------------------- 
 c)    Price(s) and volume(s) 
                                                ----------------------  ---------------------- 
                                                 Price(s)                Volume(s) 
                                                ----------------------  ---------------------- 
                                                 89.8p                   22,270 
                                                ----------------------  ---------------------- 
                                                 89.9p                   4,531 
                                                ----------------------  ---------------------- 
                                                 91.9p                   5,440 
                                                ----------------------  ---------------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume                      n/a 
 
  - Price 
 
 e)    Date of the transaction                  21 December 2022 
      ---------------------------------------  ------------------------------------------------- 
 f)    Place of the transaction                 XLON 
      ---------------------------------------  ------------------------------------------------- 
 

Enquiries:

 
 Feedback plc                             [phone] 
  Tom Oakley, CEO                          [e-mail] 
  Anesh Patel, CFO 
 
 Panmure Gordon (UK) Limited (NOMAD 
  and Broker) 
  Emma Earl/Freddy Crossley (Corporate 
  Finance) 
  Rupert Dearden (Corporate Broking)      [phone] 
 
 Walbrook PR Ltd                          Tel: [phone] or [e-mail] 
 Nick Rome/Joe Walker                     07748 325 236 or 07407 020 470 
 

About Feedback

Feedback plc helps clinical teams to make better decisions faster for patients. We design products that enhance clinician access to patient data and to their colleagues. Our unique approach centres around individual patient episodes, into which we pull relevant clinical data from hospital systems and around which we build remote clinical teams for collaboration. As a result, we produce a digital infrastructure that makes patient data available to clinicians in multiple settings, in a format that enables them to meaningfully interact with it, providing flexibility to clinicians and free movement of patients between provider settings - clinicians can practice from anywhere and patients can attend any care provider for treatment.

Our products Bleepa and CareLocker work together to deliver unparalleled value to our customers. Bleepa is our application layer and sits on top of CareLocker as our data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. Our vision is one where relevant clinical data is always available to the patient as well as to any care setting that they may attend - a federated data architecture with the patient as the tenant.

The Company has a number of growth opportunities domestically and internationally across a range of markets including the NHS, the veterinary market and private healthcare providers and its highly scalable Software as a Service ("SaaS")-based revenue model is expected to provide increasing levels of visibility as the Company grows its customer base.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHTTBTTMTMTBFT

(END) Dow Jones Newswires

December 22, 2022 07:08 ET (12:08 GMT)